Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (11) Bunse, Mario Dr. (1) Kammertöns, Thomas Dr. (2) Kieback, Elisa Dr. (1) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (4) (-) Kopp, Joachim Dr. (1) (-) Leisegang, Matthias Prof. Dr. rer. nat. (2) (-) Pezzutto, Antonio Prof. Dr. (1) 1997 (2) 1998 (2) 1999 (1) 2000 (2) 2004 (1) 2005 (2) 2006 (1) (-) 2010 (2) 2011 (2) 2013 (1) (-) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 (1) 2022 (2) Cellular Neurosciences (2) Computational Regulatory Genomics (1) Experimental Ultrahigh-Field MR (4) Genome Engineering & Disease Models (2) Genomics (1) Immune Regulation and Cancer (3) Magnetic Resonance (4) Mechanism-based Cancer Therapies (1) (-) Molecular Immunology and Gene Therapy (3) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Transgenics (2) 3 Results: Active Filter: Kopp, Joachim Dr.Leisegang, Matthias Prof. Dr. rer. nat.Pezzutto, Antonio Prof. Dr.Molecular Immunology and Gene Therapy20102016 Sort: Result score Newest to oldest Oldest to newest March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein